WAYNE, Pa., April 25, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/pbth) is investigating potential claims against the board of directors of PROLOR Biotech, Inc. ("PROLOR" or the "Company") (NYSE MKT: PBTH) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to OPKO Health, Inc. in a transaction valued at approximately $480 million.  

(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO )

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by the Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of PROLOR.  For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at rmaniskas@rmclasslaw.com or visit: www.rmclasslaw.com/cases/pbth.          

Under the terms of the transaction, shareholders of PROLOR will receive 0.9951 shares of OPKO for each share of PROLOR they own.

If you own shares of PROLOR and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/pbth.  You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com.  For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

CONTACT:  Ryan & Maniskas, LLP 
                   Richard A. Maniskas, Esquire 
                   995 Old Eagle School Rd., Suite 311 
                   Wayne, PA 19087 
                   877-316-3218
                   www.rmclasslaw.com/cases/pbth  
                   rmaniskas@rmclasslaw.com

SOURCE Ryan & Maniskas, LLP

Copyright 2013 PR Newswire

Prolor Biotech, Inc. (AMEX:PBTH)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Prolor Biotech, Inc.
Prolor Biotech, Inc. (AMEX:PBTH)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Prolor Biotech, Inc.